IP Library Granted Patent US 9,695,196
Granted Patent B2
US 9,695,196 · App. 15/319,104 · Granted Jul 4, 2017

Reactions of thiadiazolyl-oximinoacetic acid derivative compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,695,196
App. No.
15/319,104
Granted
Jul 4, 2017
Kind
B2
Abstract

This disclosure relates to an improved synthesis of cephalosporin antibiotic compounds such as ceftolozane, and compositions and methods of use thereof. Thiadiazolyl-oximinoacetic acid compounds such as TATD can be reacted to yield the activated thiadiazolyl-oximinoacetic acid methanesulfonate ester compounds useful in the manufacture of cephalosporin antibiotic compounds.

Claims (64)

1. A process for preparing a compound of formula (Z-Ib-1):

wherein:

W 1 is an acid-labile protecting group,

X 1 is Cl, Br, or I, and

R S is a C 1 -C 6 alkyl;

which comprises admixing a compound of formula (Z-I):

with a compound of formula R S SO 2 X 1 ,

in the presence of alkali metal carbonate particles having at least about 50% of the particles by weight in a range of from about 70 to about 250 micrometers,

to give the compound of formula (Z-Ib-1).

2. The process of claim 1 , wherein the alkali metal carbonate particles have at least about 70% of the particles by weight in a range of from about 70 to about 250 micrometers.

3. The process of claim 1 , wherein the alkali metal carbonate particles have at least about 80% of the particles by weight in a range of from about 70 to about 250 micrometers.

4. The process of claim 1 , wherein the alkali metal carbonate particles have at least about 90% of the particles by weight in a range of from about 70 to about 250 micrometers.

5. The process of claim 1 , wherein the alkali metal carbonate is potassium carbonate.

6. The process of claim 1 , wherein W 1 is tert-butyl.

7. The process of claim 1 , wherein R S is CH 3 .

8. The process of claim 1 , wherein the molar equivalent ratio of the compound of formula (Z-I) to the alkali metal carbonate is in a range of from about 0.6 to about 1.4.

9. The process of claim 1 , wherein the reaction temperature is in a range of from about −5 to about 20° C.

10. The process of claim 1 , wherein X 1 is Cl.

11. The process of claim 1 , wherein the molar equivalent ratio of the compound of formula R S SO 2 X 1 to the compound of formula (Z-I) is in a range of from about 1.3 to about 3.0.

12. The process of claim 1 , further comprising reacting the compound of formula (Z-Ib-1) with a compound of formula (Z-II):

to give a compound of formula (Z-III):

wherein:

X is Cl, Br, or I; and

W 2 is tert-butyl, para-methoxybenzyl, ortho-methoxybenzyl, or diphenylmethyl.

13. The process of claim 12 , further comprising reacting the compound of formula (Z-III) with a compound of formula (Z-IV):

to give a compound of formula (Z-V):

wherein:

W 3 and W 4 are each independently triphenylmethyl, tert-butyl, tert-butoxycarbonyl, or para-methoxybenzoyl; and

Anion1 is Cl, Br, I, trifluoroacetate, trifluoromethanesulfonate, or hydrogen sulfate.

14. The process of claim 13 , further comprising converting the compound of formula (Z-V):

to a compound of formula (Z-VI):

wherein

Anion3 is Cl, Br, I, methanesulfonate, toluenesulfonate, hydrogen sulfate, or sulfate.

15. The process of claim 1 , comprising reacting a compound (I):

with methanesulfonyl chloride in the presence of potassium carbonate particles having a D90 of 70-250 micrometers, to obtain a compound (Ib):

16. The process of claim 15 , wherein a total of about 1.05 to 1.30 equivalents of potassium carbonate are combined with compound (I).

17. The process of claim 15 , wherein the reaction of compound (I) occurs in a solution at a temperature of about 0-13 degrees C.

18. The process of claim 15 , wherein:

(a) a total of about 1.05 to 1.30 equivalents of potassium carbonate are combined with compound (I); and

(b) the reaction of compound (I) occurs in a solution at a temperature of about 0-13 degrees C.

19. The process of claim 18 , wherein at least about 90% of compound (I) is converted to compound (Ib).

20. The process of claim 15 , wherein the process further comprises reacting compound (Ib) with compound (II):

to give compound (III):

21. The process of claim 20 , wherein the process further comprises reacting compound (III) with compound (IV):

to give compound (V):

22. The process of claim 21 , wherein the process further comprises converting compound (V):

to compound (VI):

23. A process comprising reacting compound (I):

with methanesulfonyl chloride in the presence of an amount of potassium carbonate particles having a pre-determined D90 and at a temperature effective to provide at least 90% conversion of compound (I) to compound (Ib):

24. The process of claim 23 , wherein the reaction is performed at a temperature of about 0 to 15 degrees C.

25. The process of claim 23 , wherein the reaction is performed without an increase in temperature of greater than about 10 degrees C.

26. The process of claim 23 , wherein the reactants are maintained in contact for about 3 hours before isolating the compound (Ib).

27. The process of claim 23 , wherein at least about 97% of compound (I) is converted to compound (Ib) within about 3 hours.

28. The process of claim 23 , wherein the molar ratio of potassium carbonate to compound (I) is between about 1.05 and 1.30 in the reaction.

29. The process of claim 23 , wherein:

(a) the reaction is performed at a temperature of about 0 to 15 degrees C., and the reaction is performed without an increase in temperature of greater than about 10 degrees C.;

(b) the reaction is performed within about 1-3 hours;

(c) at least about 97% of compound (I) is converted to compound (Ib); and

(d) the molar ratio of potassium carbonate to compound (I) is between about 1.05 and 1.30 in the reaction.

30. A composition comprising compound (I):

methanesulfonyl chloride, and potassium carbonate particles having a D90 of 70-180 micrometers.

31. The composition of claim 30 , comprising a total of about 1.05 to 1.30 equivalents of potassium carbonate relative to the amount of the compound (I).

32. The composition of claim 30 , having a temperature of about 0 to 15 degrees C.

33. The composition of claim 30 , further comprising compound (Ib):

Assignments (6)
MERGER Recorded Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 7, 2017
From: SCANU, MANUEL; BENOTTI, MICHELE
To: ACS DOBFAR S.P.A.
Reel/Frame 041483/0898 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 7, 2017
From: ACS DOBFAR S.P.A.
To: CALIXA THERAPEUTICS, INC
Reel/Frame 041484/0085 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 7, 2017
From: CUBIST PHARMACEUTICALS, INC.
To: CALIXA THERAPEUTICS, INC
Reel/Frame 041485/0492 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 7, 2017
From: CALIXA THERAPEUTICS, INC
To: MERCK SHARP & DOHME CORP.
Reel/Frame 041486/0085 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2016
From: JURKAUSKAS, VALDAS; MOSHOS, KRISTOS ADRIAN
To: CUBIST PHARMACEUTICALS, INC.
Reel/Frame 040671/0491 →